Edimer Pharmaceuticals Information

View Top Employees from Edimer Pharmaceuticals

Edimer Pharmaceuticals: Working toward improving the health and quality of life of families living with XLHED. Edimer Pharmaceuticals is dedicated to developing EDI200 as a treatment for X-linked Hypohydrotic Ectodermal Dysplasia (XLHED). XLHED is a rare, orphan disease that causes a range of symptoms including lack of sweat glands, poor temperature control, respiratory problems, and hair and tooth malformations. Edimer is led by a team of seasoned biotechnology industry veterans with deep experience in drug development complemented by a strong network of world-class clinical and scientific advisers. The company is based in Cambridge, Massachusetts.

Website	http://www.edimerpharma.com
Revenue	$1.2 million
Employees	1 (0 on RocketReach)
Founded	2009
Address	55 Cambridge Pkwy Ste 102W, Cambridge, Massachusetts 02142, US
Phone	+1 866-334-4240
Technologies	JavaScript , HTML , Google Analytics +8 more (view full list)
Industry	Biotechnology Research, Manufacturing General, Biotechnology, Drug Discovery, Manufacturing, Science and Engineering, Health Care, Life Science
Keywords	Rare Diseases, Pharmaceutical, Drug Development, Genetic Disorders, Pharmaceutical Research, Biotechnology, Orphan Drugs, Pharma Research, Drug Discovery, Clinical Trials, Therapeutics, Medical Research, Healthcare, Health Solutions
Competitors	Asklepion Pharmaceuticals LLC, Afecta Pharmaceuticals, Inc., Immunohelix, Duchenne Muscular Dystrophy, Escend Pharmaceuticals , Inc. (view competitors)
SIC	SIC Code 28 Companies, SIC Code 51 Companies, SIC Code 512 Companies, SIC Code 283 Companies
NAICS	NAICS Code 45 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 456 Companies